© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Chronic Disease
WellDyne's David Skomo Highlights the Need to Reframe How Obesity Is Viewed
September 14, 2022
Payers need to reframe how they view obesity as not just a health and wellness issue, but as a progressive chronic disease that needs medication, explained David Skomo, RPh, chief operations officer at WellDyne.
Diabetes Medications Find New Life as Weight-Loss Drugs
July 21, 2022
Novo Nordisk’s Saxenda (liraglutide) and Wegovy (semaglutide) are leading the way for a new crop of drugs that reduce appetite. But their cost-effectiveness is in question, and many payers are saying no to coverage — for now.
Patients on Dupixent Experience Temporary Increase in Eosinophil Levels
July 07, 2022
The increases had no impact on the efficacy of the drug and were rarely associated with symptoms or sequelae.
HRQOL Declined in Certain Areas for Patients With AD During the Pandemic
June 24, 2022
Certain problems such as pain/discomfort, worrying and fear of the persistence/recurrence of atopic dermatitis (AD) became more common among patients with AD since the start of the COVID-19 pandemic.
Needed: A Prevention Strategy To Stop Amputations Among Minority Populations Living With Complex Diabetes
June 24, 2022
Lower limb amputations are devastating for people living with diabetes, particularly for Black Americans facing poor access to comprehensive care. A coordinated, data-driven national prevention strategy is the only way to curb this growing epidemic for all at-risk populations.
A Surge of Biologics for Severe Asthma
June 21, 2022
Six biologics are on the market and more are in the pipeline. Biologics target the inflammatory cytokines involved in the pathogenesis of asthma.
Sleep Apnea May Be Result, Not Just Cause, of Common Comorbidities
June 15, 2022
A new review argues that conditions such as hypertension, obesity, and chronic obstructive pulmonary disease may contribute to the causation of obstructive sleep apnea, not just the other way around.
Patients With Cancer Faced Heightened Economic, Social, Psychological Impacts From COVID-19
June 15, 2022
A review of multiple studies found the COVID-19 exacerbated the economic, social and psychological difficulties that patients with cancer were already facing because of their cancer.
Researchers Identify a Communications Breakdown Over Herceptin Biosimilars
June 06, 2022
If biosimilar acceptance is to grow, it’s going to take a great deal of work to improve the levels of trust between payers, patients, and oncologists.
Review Paper Argues for Broader Use of Riabni, a Rituxan Biosimilar
June 03, 2022
The review, partly funded by Amgen, the maker of Riabni, makes the case for using the biosimilar to Rituxan for all indications of the originator.